As a retired clinical laboratorian, retired hospital laboratory manager, and prostate-cancer survivor, I feel I must respond to the articles “Fewer Men Diagnosed With Prostate Cancer” and “Restricting Prostate Testing Is Considered” (U.S. News, Nov. 18 and 20, respectively). I agree that most men will die with prostate cancer rather than of it, and I can understand the effort at controlling health-care costs by reducing the number of men who might be treated for prostate cancer unnecessarily as their cancer is slow-growing and...